TRIMIDOX DIN 02184559
Health Canada record
| Active ingredient(s) | SULFADOXINE 200 MG; TRIMETHOPRIM 40 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Intramuscular |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 01-Nov-1996 |
| Current status date | 31-Aug-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Vetoquinol N A Inc. — licence 100448, currently licensed, last inspection rating C (2025-10-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SULFADOXINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00692719 | FANSIDAR TABLETS | HOFFMANN-LA ROCHE LIMITED | Tablet | SULFADOXINE 500 MG; PYRIMETHAMINE 25 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 175 | 2004-02-25 | Abbreviated New Drug Submission (ANDS) | |
| 7068 | 1996-01-30 | New Drug Submission (NDS) |
International API supply for SULFADOXINE
3 valid EDQM Certificates of Suitability from 3 holders. 0 active FDA Drug Master Files.
Request a quote for TRIMIDOX